Haiping Shi - Qilian International Chief Officer
| QLIDelisted Stock | USD 8.08 0.12 1.46% |
Executive
Haiping Shi is Chief Officer of Qilian International Holding
| Age | 51 |
| Phone | 86 02 8647 75180 |
| Web | https://www.qlsyy.net |
Qilian International Management Efficiency
The company has Return on Asset of (0.0282) % which means that on every $100 spent on assets, it lost $0.0282. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1636) %, meaning that it generated no profit with money invested by stockholders. Qilian International's management efficiency ratios could be used to measure how well Qilian International manages its routine affairs as well as how well it operates its assets and liabilities.Qilian International Holding has 1.77 M in debt with debt to equity (D/E) ratio of 0.23, which may show that the company is not taking advantage of profits from borrowing. Qilian International has a current ratio of 1.9, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Qilian to invest in growth at high rates of return.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| James Marken | ANI Pharmaceuticals | 61 | |
| Larry Miller | Phibro Animal Health | 60 | |
| Camilo Camacho | Procaps Group SA | 50 | |
| YatPui Au | Regencell Bioscience Holdings | 50 | |
| Christopher Mutz | ANI Pharmaceuticals | 53 | |
| Stephen Wargacki | Aquestive Therapeutics | 46 | |
| Sherry Korczynski | Aquestive Therapeutics | N/A | |
| Jose Vieira | Procaps Group SA | 58 | |
| Carlos Russo | Procaps Group SA | 39 | |
| Thomas Rowland | ANI Pharmaceuticals | 57 | |
| Christopher MD | Collegium Pharmaceutical | N/A | |
| Rita Keynan | Painreform | 55 | |
| Stephen DMD | Painreform | N/A | |
| Bart Dunn | Collegium Pharmaceutical | N/A | |
| Carl MD | Aquestive Therapeutics | 54 | |
| Mary MD | ANI Pharmaceuticals | N/A | |
| Krista Davis | ANI Pharmaceuticals | 50 | |
| Ori Gutwerg | ANI Pharmaceuticals | 49 | |
| Robert Arnold | Aquestive Therapeutics | N/A | |
| Tien Chau | Regencell Bioscience Holdings | 54 | |
| Kenneth Marshall | Aquestive Therapeutics | 65 | |
Management Performance
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0282 |
Qilian International Leadership Team
Elected by the shareholders, the Qilian International's board of directors comprises two types of representatives: Qilian International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Qilian. The board's role is to monitor Qilian International's management team and ensure that shareholders' interests are well served. Qilian International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Qilian International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dingqian Liu, Executive Director | ||
| Chen Xin, Chief Officer | ||
| Yaxuan Zhai, Chief Officer | ||
| Zhanchang Xin, President, Chairman | ||
| Haiping Shi, Chief Officer |
Qilian Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Qilian International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0282 | |||
| Profit Margin | (0.17) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 16.84 M | |||
| Shares Outstanding | 7.15 M | |||
| Shares Owned By Insiders | 77.44 % | |||
| Shares Owned By Institutions | 0.04 % | |||
| Number Of Shares Shorted | 28.94 K | |||
| Price To Earning | 10.88 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Qilian Stock
If you are still planning to invest in Qilian International check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qilian International's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |